ALLEGAN – The Perrigo Company announced Thursday that it has received approval from the U.S. Food and Drug Administration to market an over-the-counter version of Nicorette gum, which is an aid to smoking cessation.
The overall market for OTC nicotine gum and lozenge products is estimated at
approximately $750 million annually at all retail outlets.
The FDA approval was for Nicotine Polacrilex Gum USP, 2 mg (base) and 4 mg (base) (Orange, Coated).
“This approval of orange-flavored, coated nicotine gum extends our leading store brand position,? said Perrigo Chairman and CEO Joseph Papa. ?Our expanded range of smoking cessation products also includes coated mint-flavored gum, coated fruit-flavored gum, uncoated gum and lozenges.?
Perrigo is a leading global healthcare supplier that develops,
manufactures and distributes over-the-counter and prescription
pharmaceuticals, nutritional products, active pharmaceutical ingredients
and consumer products. The company is the world’s largest
manufacturer of OTC pharmaceutical products for the store brand market. The
Company’s primary markets and locations of manufacturing facilities are the
United States, Israel, Mexico and the United Kingdom.
For more information, click on Perrigo.Com
a>>
